Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

The show is a joint project by artists Bert and Elise Holland, Charlotte, Clair, Evie, Kate, Spencer James and Steven Hart.

Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...

Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern University and Case Western Reserve University have developed the first ...

Researchers uncover a link between impaired glutathione–ascorbate metabolism and early dopamine increases in Huntington's ...

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

Scientists have developed a novel polymer-based therapy that could slow Huntington's disease progression by preventing ...

Saturday saw the first Team Hope walk in Tyler to benefit the Huntington’s Disease Society of America. Team Hope works to ...

A polymer has been developed to optimize the use of a peptide to treat Huntington’s disease in mice.